Your browser doesn't support javascript.
loading
Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors.
Turchick, Audrey; Zimmermann, Astrid; Chiu, Li-Ya; Dahmen, Heike; Elenbaas, Brian; Zenke, Frank T; Blaukat, Andree; Vassilev, Lyubomir T.
Affiliation
  • Turchick A; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA.
  • Zimmermann A; Translational Innovation Platform Oncology and Immuno-Oncology, the healthcare business of Merck KGaA, Darmstadt, Germany.
  • Chiu LY; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA.
  • Dahmen H; Translational Innovation Platform Oncology and Immuno-Oncology, the healthcare business of Merck KGaA, Darmstadt, Germany.
  • Elenbaas B; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA.
  • Zenke FT; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA.
  • Blaukat A; Translational Innovation Platform Oncology and Immuno-Oncology, the healthcare business of Merck KGaA, Darmstadt, Germany.
  • Vassilev LT; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, MA.
Mol Cancer Ther ; 22(7): 859-872, 2023 07 05.
Article in En | MEDLINE | ID: mdl-37079339
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ataxia Telangiectasia / Tumor Suppressor Protein p53 Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ataxia Telangiectasia / Tumor Suppressor Protein p53 Limits: Humans Language: En Year: 2023 Type: Article